Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
批准号:
7687221
负责人:
ARUNA V SARMA
金额:
$56.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-25 至 2014-07-31
关键词:
AffectAgeAge FactorsAge-YearsAgingAmericanAncillary StudyAndrogensBiologicalBiological MarkersBiologyBladderCardiacCardiovascular DiseasesCollectionComplexComplicationComplications of Diabetes MellitusDataDatabasesDecreased LibidoDiabetes MellitusDiseaseDisease MarkerEducationElderlyEpidemiologyErectile dysfunctionFamilyFemaleFrequenciesFunctional disorderGenetic Predisposition to DiseaseGenitourinary systemGlycosylated hemoglobin AGoalsGrowthHealthHealthcare SystemsHigh Risk WomanHypogonadismIncidenceInsulin-Dependent Diabetes MellitusInterventionInvestigationKidney DiseasesMagnetic Resonance ImagingMapsMeasuresNational Institute of Diabetes and Digestive and Kidney DiseasesNeuropathyParentsParticipantPatient Self-ReportPatientsPerceived quality of lifePeripheral Nervous System DiseasesPersonsPhenotypePolicy MakerPopulationPrevalencePreventive InterventionProstateProstate-Specific AntigenProstatic DiseasesQuality of lifeQuestionnairesRandomized Controlled TrialsRecruitment ActivityRegulationReportingRetinal DiseasesRiskRisk FactorsSamplingSerumSeveritiesSexual DysfunctionSpecimenSurveysSymptomsTestosteroneTimeTime StudyUrinary IncontinenceVascular DiseasesWeightWomanage relatedburden of illnesscatalystcohortcostdepressiondiabetes controldiabetes mellitus therapydiabeticearly onsetexperiencefollow-upgene environment interactiongenome wide association studyglycemic controlhealth related quality of lifeinsightinstrumentinterestintimal medial thickeninglower urinary tract symptomsmeetingsmenmultidisciplinarynovelpreventpublic health relevanceresearch studyresponseurologic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Urinary incontinence, lower urinary tract symptoms and sexual dysfunction are common health problems that reduce quality of life and markedly increase in prevalence and incidence with advancing age. Earlier onset and increased severity of those conditions among men and women with diabetes result in costly and debilitating symptoms. However, data to define incidence, associated factors and interventions to reduce the risk of developing these complications among men and women with type 1 diabetes (T1D) are limited. We have assembled a multidisciplinary team to implement an ancillary study to the Epidemiology of Diabetes Intervention and Complication (EDIC) study, a major ongoing NIDDK research study. The collection of additional survey information from EDIC participants, combined with existing and new biological specimens, will repurpose this important study to measure the new onset of urological symptoms during an important window of time in which the frequency of urological complications is accelerating. Our hypothesis is that urological complications of diabetes impair quality of life (QOL) and that diabetic and systemic factors can be identified that predict men and women at risk for these complications. Our specific aims are to 1) measure the onset and progression of urinary incontinence (UI), lower urinary tract symptom severity (LUTS), and sexual dysfunction (SDF) in men and women with T1D and determine the influence of glycemic therapy and diabetes severity on these complications; 2) determine the influence of low testosterone levels and prostate growth on the associations between glycemic therapy, diabetes severity and the complications of LUTS and SDF in men and 3) measure the impact of the onset and progression of urologic complication on health related QOL I men and women with T1D. The timing of this study is critical in order to capture the upswing in incidence of urological complications as the EDIC cohort reaches 50 years of age. The completion of these aims will provide comprehensive insight into the association between urologic complication and T1D and the impact of these symptoms on QOL. Predictive and protective factors will be identified that map out strategies for intervention and prevention studies. Findings from this proposal may also reveal important relationships between diabetic factors and ageing, bladder and prostate biology, and provide a data repository for biomarker discovery and genome wide association studies.
Public Health Relevance: (adapted from the application) The proposed study is likely to offer an opportunity to complete important investigations on urological complications of type 1diabetes by repurposing the DCCT/EDIC parent study and its established cohorts. The collection of additional survey information from recruited study participants is likely to give a one-time chance to capture incident urological complications and the impact of these conditions on quality of life. The precise data from this study will be important to educate patients and their families, help develop biomarkers of urological complications and provide refined phenotypes for genetic susceptibility studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Professional Development Core
-
批准号:10506492
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2022
-
负责人:ARUNA V SARMA
-
依托单位:
Professional Development Core
-
批准号:10705181
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2022
-
负责人:ARUNA V SARMA
-
依托单位:
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes
-
批准号:10406303
-
项目类别:
-
资助金额:$65.02万
-
财政年份:2021
-
负责人:ARUNA V SARMA
-
依托单位:
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes
-
批准号:10606540
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2021
-
负责人:ARUNA V SARMA
-
依托单位:
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes
-
批准号:10205344
-
项目类别:
-
资助金额:$72.3万
-
财政年份:2021
-
负责人:ARUNA V SARMA
-
依托单位:
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
-
批准号:8144537
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2009
-
负责人:ARUNA V SARMA
-
依托单位:
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
-
批准号:7938939
-
项目类别:
-
资助金额:$51.54万
-
财政年份:2009
-
负责人:ARUNA V SARMA
-
依托单位:
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
-
批准号:8305070
-
项目类别:
-
资助金额:$51.36万
-
财政年份:2009
-
负责人:ARUNA V SARMA
-
依托单位:
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
-
批准号:8515391
-
项目类别:
-
资助金额:$53.38万
-
财政年份:2009
-
负责人:ARUNA V SARMA
-
依托单位:
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes
-
批准号:8125097
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2009
-
负责人:ARUNA V SARMA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: